Pathology and Forensic Medicine
A topic in the Science corpus, drawn from 3,205 papers.
Trusted voices in Pathology and Forensic Medicine
Ordered by the trust Pathology and Forensic Medicine's own network concentrates on each researcher, most first.
- M. F. Holick — trusted by 59 researchers here
- Jerzy Jurka — trusted by 42 researchers here
- Jörn Diedrichsen — trusted by 35 researchers here
- B. Hollis — trusted by 24 researchers here
- John Rognes — trusted by 13 researchers here
- D. Allan Butterfield — trusted by 16 researchers here
- D. Sidransky — trusted by 16 researchers here
- D. Yellon — trusted by 14 researchers here
- E. Brunt — trusted by 21 researchers here
- Larry Cahill — trusted by 15 researchers here
- Myron F. Goodman — trusted by 12 researchers here
- TA Wynn — trusted by 14 researchers here
Most-cited papers in Pathology and Forensic Medicine
Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010, International Journal of Cancer) — 21,956 citations
- Investigation of the freely available easy-to-use software ‘EZR' for medical statistics (2012, Bone Marrow Transplantation) — 17,041 citations
- Multiple Sclerosis (2007, Journal - Michigan State Medical Society) — 11,454 citations
- Mutations of the BRAF gene in human cancer (2002, Nature) — 10,701 citations
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000, Nature) — 10,272 citations
- Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. (2011, Journal of Clinical Endocrinology and Metabolism) — 10,197 citations
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011, Annals of Neurology) — 9,812 citations
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (2016, Hepatology) — 9,590 citations
- Signatures of mutational processes in human cancer (2013, Nature) — 9,146 citations
- The Cancer Genome Atlas Pan-Cancer Analysis Project (2013) — 8,331 citations
- Polyphenols: food sources and bioavailability. (2004, American Journal of Clinical Nutrition) — 7,850 citations
- Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012, Nature) — 7,754 citations
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005, The Lancet) — 7,387 citations
- Vitamin D deficiency. (2007, New England Journal of Medicine) — 7,203 citations
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis (2001, Annals of Neurology) — 7,112 citations
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. (2017, Lancet Neurology) — 6,885 citations
- A gene-expression signature as a predictor of survival in breast cancer. (2002, New England Journal of Medicine) — 6,396 citations
- Comprehensive molecular characterization of gastric adenocarcinoma (2014, Nature) — 5,955 citations
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (2004, New England Journal of Medicine) — 5,932 citations
- Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade (2017, Science) — 5,893 citations
- The Oswestry Disability Index. (2000, Spine) — 5,803 citations
- The International Classification of Headache Disorders: 2nd edition (2003) — 5,792 citations
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. (2020, New England Journal of Medicine) — 5,608 citations
- Cancer Statistics, 2006 (2006, Ca) — 5,579 citations
- Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma (2025, Blood Advances) — 5,541 citations
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. (2005, New England Journal of Medicine) — 5,515 citations
- Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. (2002) — 5,458 citations
- Expert Commentary. (2002, Histopathology) — 5,260 citations
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” (2005, Annals of Neurology) — 5,239 citations
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials (2007) — 5,142 citations
- 5-Fluorouracil: mechanisms of action and clinical strategies (2003, Nature Reviews. Cancer) — 5,134 citations
- The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. (2000, Pharmacological Reviews) — 5,077 citations
- Cisplatin in cancer therapy: molecular mechanisms of action (2014, European Journal of Pharmacology) — 5,019 citations
- Definition and classification of cancer cachexia: an international consensus. (2011, The Lancet Oncology) — 4,957 citations
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (2017, New England Journal of Medicine) — 4,882 citations
- Sorafenib in advanced clear-cell renal-cell carcinoma. (2007, New England Journal of Medicine) — 4,849 citations
- Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. (2014, Journal of Clinical Oncology) — 4,784 citations
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 (2005, Nature Immunology) — 4,711 citations
- Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. (2014, Physiological Reviews) — 4,703 citations
- The World Health Organization Classification of Lymphoid Neoplasms (2013) — 4,677 citations
- The Consensus Molecular Subtypes of Colorectal Cancer (2015, Nature Medicine) — 4,640 citations
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency (2015, New England Journal of Medicine) — 4,624 citations
- Revised response criteria for malignant lymphoma. (2007, Journal of Clinical Oncology) — 4,475 citations
- Plant polyphenols as dietary antioxidants in human health and disease (2009, Oxidative Medicine and Cellular Longevity) — 4,431 citations
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling (2007, Science) — 4,374 citations
- Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies (2014) — 4,314 citations
- Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. (2000, New England Journal of Medicine) — 4,264 citations
- Mutational landscape and significance across 12 major cancer types (2013, Nature) — 4,262 citations
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004, Blood) — 4,201 citations
- Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. (2002, New England Journal of Medicine) — 4,196 citations
Most active researchers
By papers in this topic: a volume measure, not trust.
- Louis Staudt — 26 papers
- M. F. Holick — 24 papers
- Andreas Rosenwald — 22 papers
- Gad Getz — 21 papers
- Bert Vogelstein — 20 papers
- Kenneth W. Kinzler — 18 papers
- Hans Lassmann — 18 papers
- Matthew Meyerson — 18 papers
- C. Lucchinetti — 16 papers
- L. Diaz — 15 papers
- George W. Wright — 15 papers
- Eric S. Lander — 15 papers